These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9730713)

  • 1. Plasma carnitine levels in patients undergoing hemodialysis.
    Reddi AS; Moquete M; Keshav G; DeAngelis B; Frank O; Baker H
    Nephron; 1998 Sep; 80(1):87-8. PubMed ID: 9730713
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood levels of chromium in diabetic and nondiabetic hemodialysis patients.
    Romero RA; Salgado O; Rodríguez-Iturbe B; Tahán JE
    Transplant Proc; 1996 Dec; 28(6):3382-4. PubMed ID: 8962320
    [No Abstract]   [Full Text] [Related]  

  • 3. [Level of total plasma carnitine in patients with chronic renal failure in the course of diabetes and other etiologies treated with hemodialysis].
    Gumprecht J; Snit M; Zukowska-Szczechowska E; Grzeszczak W; Moczulski D; Jendryczko A
    Pol Arch Med Wewn; 1995 Nov; 94(5):403-9. PubMed ID: 8833937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoglobin A1c in hemodialysis patients: should one size fit all?
    Ix JH
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1539-41. PubMed ID: 20671219
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma lipoprotein(a) levels in patients having chronic renal failure with and without diabetes mellitus.
    Makino K; Josephson MA; Fellner SK; Scanu AM
    Atherosclerosis; 1993 Jan; 98(2):255-6. PubMed ID: 8457265
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences in serum ionized and total magnesium values during chronic renal failure between nondiabetic and diabetic patients: a cross-sectional study.
    Dewitte K; Dhondt A; Giri M; Stöckl D; Rottiers R; Lameire N; Thienpont LM
    Diabetes Care; 2004 Oct; 27(10):2503-5. PubMed ID: 15451927
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease.
    Evans AM; Faull RJ; Nation RL; Prasad S; Elias T; Reuter SE; Fornasini G
    Kidney Int; 2004 Oct; 66(4):1527-34. PubMed ID: 15458447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.
    Kopecky C; Genser B; Drechsler C; Krane V; Kaltenecker CC; Hengstschläger M; März W; Wanner C; Säemann MD; Weichhart T
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):224-31. PubMed ID: 25424990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-glucose infusion given before hemodialysis increases IGF-I in type 2 diabetes patients with chronic kidney disease.
    Lindgren BF; Jacobson SH; Brismar K
    Growth Horm IGF Res; 2010 Dec; 20(6):422-6. PubMed ID: 21051252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters.
    Bodlaj G; Berg J; Pichler R; Sailer T; Biesenbach G
    J Nephrol; 2004; 17(1):112-7. PubMed ID: 15151267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dialysis on serum carnitine, free fatty acids, and triglyceride levels in man and the rat.
    Bartel LL; Hussey JL; Shrago E
    Metabolism; 1982 Sep; 31(9):944-7. PubMed ID: 7121265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of plasma fructosamine in non-diabetic and diabetic chronic renal failure].
    Delattre J; Rottembourg J; Thuillier-Juteau Y; Allouache A; Villiamier C; Jaudon MC; Galli A
    Presse Med; 1989 Nov; 18(36):1781-4. PubMed ID: 2530565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnitine concentrations in dialysed and undialysed patients with chronic renal insufficiency.
    Rodriguez-Segade S; Alonso de la Peña C; Paz M; Novoa D; Romero R; Arcocha V; Del Rio R
    Ann Clin Biochem; 1986 Nov; 23 ( Pt 6)():671-5. PubMed ID: 3800294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodialysis for French diabetic patients.
    Friedman EA
    Nephrol Dial Transplant; 1999 Jan; 14(1):30-1. PubMed ID: 10052470
    [No Abstract]   [Full Text] [Related]  

  • 15. [Levels of L-carnitine in serum of patients with chronic renal failure treated by hemodialysis (HD)].
    Wanic-Kossowska M; Bombicki K; Kozioł L; Czarnecki R
    Pol Arch Med Wewn; 1998 Apr; 99(4):314-22. PubMed ID: 9760819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal dialysis for patients with diabetes and end-stage renal disease: sorting out the biases?
    Finkelstein FO; Smith JD
    ASAIO J; 1996; 42(1):1-3. PubMed ID: 8808447
    [No Abstract]   [Full Text] [Related]  

  • 17. Carnitine in hemodialysis patients.
    Butler B
    Nephrol Nurse; 1983; 5(5):32-3. PubMed ID: 6557366
    [No Abstract]   [Full Text] [Related]  

  • 18. Parathyroid hormone in patients with diabetes mellitus and end-stage renal disease on chronic haemodialysis.
    Pabico RC; Rivero AJ; McKenna BA; Freeman RB
    Proc Eur Dial Transplant Assoc; 1983; 19():221-6. PubMed ID: 6878235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in nutritional parameters after initiation of chronic hemodialysis.
    Pupim LB; Kent P; Caglar K; Shyr Y; Hakim RM; Ikizler TA
    Am J Kidney Dis; 2002 Jul; 40(1):143-51. PubMed ID: 12087572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis.
    Csiky B; Nyul Z; Tóth G; Wittmann I; Melegh B; Rauh M; Rascher W; Sulyok E
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):735-40. PubMed ID: 20658442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.